May 8, 2018 / 9:50 PM / in 6 months

BRIEF-Xenon Pharmaceuticals Enters Into At-The-Market Equity Offering Sales Agreement With Stifel, Nicolaus & Co

May 8 (Reuters) - Xenon Pharmaceuticals Inc:

* XENON PHARMACEUTICALS INC - ON MAY 8, CO ENTERED INTO AN AT—MARKET EQUITY OFFERING SALES AGREEMENT WITH STIFEL, NICOLAUS & COMPANY - SEC FILING

* XENON PHARMACEUTICALS - SALES AGREEMENT TO SELL COMMON SHARES OF CO HAVING SALES PROCEEDS OF UP TO $30 MILLION THROUGH "AT MARKET" EQUITY OFFERING PROGRAM Source text: (bit.ly/2KN4M0A) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below